Psychology Wiki

Changes: Mesoridazine


Back to page

(New page: {{BioPsy}} {{drugbox | IUPAC_name = 10-{2-[(RS)1-Methylpiperidin-2-yl]ethyl}-2-methylsulfinyl-10H-phenothiazine | image = Mesoridazine.png | CAS_number = 5588-33-0 | ATC_prefix = N05 | ...)
Line 22: Line 22:
It was withdrawn from the United States market in 2004.
It was withdrawn from the United States market in 2004.
==See also==
*[[Phenothiazine derivative]]

Latest revision as of 00:27, April 24, 2008

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

Mesoridazine chemical structure

IUPAC name
CAS number
ATC code


Chemical formula {{{chemical_formula}}}
Molecular weight 386.576 g/mol
Metabolism Hepatic/Renal
Elimination half-life 24 to 48 hours
Excretion Biliary/Renal
Pregnancy category C (USA)
Legal status Rx-only
Routes of administration oral, intravenous

Mesoridazine besylate (trade name Serentil) is a neuroleptic drug that is used in the treatment of schizophrenia, organic brain disorders, psychoneuroses, and alcoholism. It is the besylate salt of a metabolite of thioridazine. It exerts its actions through a central adrenergic-blocking, a dopamine-blocking, a serotonin-blocking, and a weak anticholinergic action. It also exerts part of its actions through depression of hypothalamic centers, like other phenothiazines.

It was withdrawn from the United States market in 2004.

See alsoEdit

This page uses Creative Commons Licensed content from Wikipedia (view authors).

Around Wikia's network

Random Wiki